Patents Assigned to Imagenetix, Inc.
-
Publication number: 20120156286Abstract: Disclosed are compositions comprising Coenzyme Q10 and a cetylated fatty acid blend, pharmaceutical formulations comprising the same and methods of increasing the systemic concentration of Coenzyme Q10 in an individual, comprising administering the same to the individual.Type: ApplicationFiled: July 27, 2011Publication date: June 21, 2012Applicant: IMAGENETIX, INC.Inventor: William P. SPENCER
-
Publication number: 20120029078Abstract: The teachings herein are directed to antibacterial and anti-inflammatory pharmaceutical compositions that include myristic acid. Further embodiments herein are directed to methods of administering sufficient amounts of myristic compositions to patients in need thereof in order to prevent or treat inflammation and/or bacterial infection. Myristic acid has been established to outperform other cetylated fatty acids in treating infection and inflammation, such as 1-TDC which includes cetylated myristic acid. The compositions and methods provided herein can further be used with additional anti-inflammatory, antibacterial, and delivery agents.Type: ApplicationFiled: March 2, 2011Publication date: February 2, 2012Applicant: IMAGENETIX, INC.Inventors: Robert L. Hesslink, JR., William P. Spencer
-
Patent number: 7776914Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.Type: GrantFiled: June 16, 2009Date of Patent: August 17, 2010Assignee: Imagenetix, Inc.Inventors: William P. Spencer, Patrick S. Millsap
-
Patent number: 7612111Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.Type: GrantFiled: March 22, 2004Date of Patent: November 3, 2009Assignee: Imagenetix, Inc.Inventors: William P. Spencer, Patrick S. Millsap
-
Publication number: 20090252692Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.Type: ApplicationFiled: June 16, 2009Publication date: October 8, 2009Applicant: IMAGENETIX, INC.Inventors: William P. SPENCER, Patrick S. MILLSAP
-
Publication number: 20050208162Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.Type: ApplicationFiled: March 22, 2004Publication date: September 22, 2005Applicant: IMAGENETIX, INC.Inventors: William Spencer, Patrick Millsap